Successful Treatment of Chronic Inflammatory Enteropathy in 2-Year-Old Yorkshire Terier. Case Report

Abstract Chronic enteropathy in dogs represents a significant clinical challenge that often requires innovative therapeutic strategies for effective management. This case study investigated the simultaneous use of budesonide, cannabidiol (CBD) oil and probiotics. Budesonide represents a corticoid therapy primarily used in human medicine for autoimmune diseases. Cannabidiol oil is one of the cannabinoids that does not affect sensory perception and is known for its anti-inflammatory properties. Probiotics help maintain gut microbiota balance as a treatment modality for chronic enteropathy in dogs. This report details the clinical symptoms, diagnosis, and treatment plan, highlighting the positive response seen in the patient. The findings suggested that the combination of budesonide, CBD oil, and probiotics may be a beneficial strategy for the treatment of chronic enteropathy in dogs.